Total Payments
$2,863
2024 Payments
$810.01
Companies
23
Transactions
187
Medicare Patients
2,357
Medicare Billing
$420,833
Payment Breakdown by Category
Food & Beverage$2,863 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,863 | 187 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $825.09 | 77 | $0 (2024) |
| Biogen, Inc. | $203.35 | 12 | $0 (2024) |
| Allergan, Inc. | $191.59 | 6 | $0 (2022) |
| Lilly USA, LLC | $174.59 | 11 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $167.64 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $143.30 | 9 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $139.50 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $116.07 | 6 | $0 (2024) |
| PFIZER INC. | $114.32 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $113.57 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $810.01 | 52 | ABBVIE INC. ($232.59) |
| 2023 | $636.23 | 32 | ABBVIE INC. ($245.64) |
| 2022 | $385.39 | 36 | ABBVIE INC. ($198.75) |
| 2021 | $475.70 | 38 | AbbVie Inc. ($148.11) |
| 2020 | $161.12 | 11 | Biogen, Inc. ($66.49) |
| 2019 | $120.96 | 8 | Janssen Pharmaceuticals, Inc ($36.55) |
| 2018 | $91.37 | 5 | Medtronic USA, Inc. ($62.09) |
| 2017 | $182.43 | 5 | Collegium Pharmaceutical, Inc. ($125.00) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neurology | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Central Nervous System | ||||||
| 10/04/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Neurology | ||||||
| 09/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Adenosine A2A Receptors | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Neuropsychiatry | ||||||
| 08/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $48.08 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 07/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: PAIN | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 727 | 1,010 | $266,761 | $127,080 |
| 2022 | 18 | 719 | 1,024 | $344,690 | $136,654 |
| 2021 | 14 | 534 | 725 | $150,352 | $97,878 |
| 2020 | 13 | 377 | 524 | $80,557 | $59,221 |
Total Patients
2,357
Total Services
3,283
Medicare Billing
$420,833
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 261 | $40,977 | $19,656 | 48.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 56 | 56 | $38,304 | $19,209 | 50.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 57 | 180 | $30,780 | $15,848 | 51.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 103 | $22,763 | $10,967 | 48.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 35 | 49 | $20,972 | $10,836 | 51.7% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 35 | 35 | $17,395 | $8,825 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $15,370 | $7,301 | 47.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 41 | 41 | $22,920 | $7,090 | 30.9% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 35 | 35 | $16,940 | $6,779 | 40.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 19 | 23 | $6,992 | $3,614 | 51.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 16 | 18 | $6,588 | $3,408 | 51.7% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 24 | 24 | $5,208 | $2,702 | 51.9% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 21 | 21 | $4,788 | $2,484 | 51.9% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 21 | 21 | $3,906 | $2,030 | 52.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $4,137 | $1,984 | 48.0% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 24 | 24 | $3,672 | $1,893 | 51.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 24 | 24 | $3,600 | $1,706 | 47.4% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 21 | 21 | $1,449 | $748.44 | 51.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 67 | 67 | $54,638 | $24,236 | 44.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 77 | 225 | $66,735 | $20,978 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 231 | $36,375 | $17,510 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $29,874 | $12,167 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 102 | $22,759 | $11,195 | 49.2% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 44 | 56 | $26,741 | $11,079 | 41.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 36 | 44 | $26,978 | $10,028 | 37.2% |
About Kishan Patel
Kishan Patel is a Neurology healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1346473071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kishan Patel has received a total of $2,863 in payments from pharmaceutical and medical device companies, with $810.01 received in 2024. These payments were reported across 187 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,863).
As a Medicare-enrolled provider, Patel has provided services to 2,357 Medicare beneficiaries, totaling 3,283 services with total Medicare billing of $420,833. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Forest Hills, NY
- Active Since 08/28/2009
- Last Updated 10/01/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346473071
Products in Payments
- UBRELVY (Drug) $365.01
- QULIPTA (Drug) $338.00
- BOTOX (Biological) $313.67
- NURTEC ODT (Drug) $201.05
- Austedo XR (Drug) $129.60
- Xtampza ER (Drug) $125.00
- TYSABRI (Biological) $121.48
- KESIMPTA (Drug) $116.07
- EMGALITY (Drug) $114.23
- XARELTO (Drug) $113.57
- INGREZZA (Drug) $111.50
- ACTIVA (Device) $95.40
- VUMERITY (Drug) $81.87
- Leqembi (Drug) $81.57
- Nourianz (Drug) $80.83
- AMYVID (Drug) $60.36
- ONGENTYS (Drug) $56.14
- NEUROSTAR TMS THERAPY SYSTEM (Device) $48.08
- GOCOVRI (Drug) $40.85
- VaPro (Device) $40.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Forest Hills
Enrico Fazzini, Do, DO
Neurology — Payments: $201,759
Neurology $201,759
Dr. Marina Neystat, M.d, M.D
Neurology — Payments: $29,600
Neurology $29,600
Dr. Seniha Inan, Md, MD
Neurology — Payments: $4,071
Neurology $4,071
Dr. Carlisle St. Martin, M.d, M.D
Neurology — Payments: $989.93
Neurology $989.93
Yelena Amitina, M.d, M.D
Neurology — Payments: $554.99
Neurology $554.99
Dr. Ira Casson, Md, MD
Neurology — Payments: $428.00
Neurology $428.00